SS Innovations International (SSII) Stock Price, News & Analysis

Company Overview

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.

Key Stats

• Today's Range: $6.55 to $7.00
• 50-Day Range: $3.24 to $8.45
• 52-Week Range: $0.32 to $22.42
• Volume: 33,187 shs
• Average Volume: 128,308 shs
• Market Capitalization: $1.31 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SSII Stock Analysis - Frequently Asked Questions

How have SSII shares performed this year?

SS Innovations International's stock was trading at $10.09 on January 1st, 2025. Since then, SSII shares have decreased by 32.9% and is now trading at $6.77.

Who are SS Innovations International's major shareholders?

Top institutional shareholders of SS Innovations International include Forum Financial Management LP (0.03%), Geode Capital Management LLC (0.01%) and AlTi Global Inc. (0.01%).

How do I buy shares of SS Innovations International?

Shares of SSII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Technology Services
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SSII
• Previous Symbol: NASDAQ:SSII
• CIK: 1676163
• Web: N/A
• Phone: (954) 478-1410
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$19.15 million
• Net Margins: -67.73%
• Pretax Margin: -67.73%
• Return on Equity: -70.64%
• Return on Assets: -32.95%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.18
• Quick Ratio: 2.22

Sales & Book Value

• Annual Sales: $20.65 million
• Price / Sales: 61.97
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.08 per share
• Price / Book: 82.63

Miscellaneous

• Outstanding Shares: 193,600,000
• Free Float: N/A
• Market Cap: $1.28 billion
• Optionable: N/A
• Beta: N/A